Network biology connects the dots for human health
Networks form the backbone of transportation infrastructure, communication systems, and even the neurons in our brains. When computational scientists map data points into networks—quite literally connecting the dots—the patterns they reveal can provide significant insights.
In network biology, computational and biological scientists collaborate to find the patterns in abundant and complex molecular and biomedical data. They use graph algorithms, machine learning, and artificial intelligence to model biological mechanisms, including those underlying cancer and aging.
“Similar to a car manual, networks show you the relationship between the parts,” said Tijana Milenkovic, network biology expert and Frank M. Freimann Collegiate Professor of Engineering in the Department of Computer Science and Engineering at the University of Notre Dame.
“You see how each part of a biological system—gene, protein, neuron—contributes to the system’s overall performance and what happens if a part fails or is removed.”
In a paper published in Bioinformatics Advances, Milenkovic and 36 other researchers from over 25 universities and labs chart a comprehensive roadmap for network biology’s current state and future directions.
Networks allow researchers to represent biological systems as interconnected entities rather than collections of individual components. Biomolecules, such as DNA, amino acids, or proteins, are represented as points on a network while the links between the points indicate their interactions—physical, functional, or chemical.
Network biology promises to move medicine beyond its current one-size-fits-all approach. Instead of giving the same treatment to all patients with the same disease, treatments could be tailored to each individual’s unique molecular profile.
Also, networks show how a drug interacts with multiple biological targets, thereby revealing the ways in which a drug previously used to treat one condition might have the potential to treat another.
The paper, which originated from an NSF-funded workshop at Notre Dame, identifies five prominent research subfields within network biology: inference and comparison of biological networks, multimodal data integration and heterogeneous networks, higher-order network analysis, machine learning on networks, and network-based personalized medicine.
Milenkovic noted that, despite numerous advances, challenges remain in the field, such as enhanced data generation, developing novel algorithms, refining evaluation frameworks, and a wider adoption of innovations.
“The goal is not just to predict likely interactions between biomolecules or identify interesting patterns in complex data,” said Milenkovic. “We want to help explain the underlying biological mechanisms that yield these patterns.”
Latest Research
- From reaction to resolution: The future of allergy treatmentTwelve-year-old Lauren Eglite was thrilled to attend a Notre Dame football game with her father, Erik, in 2017, even though her acute peanut allergy demands constant vigilance. She was even more excited when the stadium’s brand-new video board aired an NBC Fighting…
- New Study Highlights Mother-Child Link for Anemia in The GambiaAnemia is a "silent epidemic." It affects nearly 2 billion people globally, yet many people ignore its symptoms. Typically caused by the consumption of iron-deficient foods, anemia develops gradually. Its symptoms—such as fatigue, weakness, and shortness of breath—are frequently dismissed or misattributed.
- Megan McDermott joins ND–IBM Tech Ethics Lab as new Notre Dame directorThe Notre Dame–IBM Technology Ethics Lab, a critical component of the Institute for Ethics and the Common Good (ECG) and the Notre…
- Jenkins Center for Virtue Ethics receives grant to advance love-based ethical frameworkThe University of Notre Dame has received a $10 million grant from the John Templeton Foundation to support a project titled Love and Social Transformation: Empowering Scholars and Social Innovators to Develop the Love Ethic.
- ND-GAIN releases latest Country Index updateThe lastest update to the University of Notre Dame’s Global Adaptation Initiative's (ND-GAIN) Country Index is now live. The ND-GAIN team will release a second Country Index update in late Fall, which includes…
- In sub-Saharan Africa, 1 in 6 cancer medications found to be defectiveSerious quality defects were found in a significant number of cancer medications from sub-Saharan Africa, according to new research from the University of Notre Dame.